Concord Biotech Share Price

Small Cap | Pharmaceuticals and health care | NSE: CONCORDBIO | BSE: 543960

₹1,637.85 image-37.70 (-2.25 %)

Last Updated: 21 Feb 2025 04:01 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 1,729.95

High (₹) 1,729.95

Low (₹) 1,635.00

Prev. Close (₹) 1,675.55

Volume 1,275

VWAP (₹) 1,650.48

ROCE (%) 26.41

Industry P/E 43.99

TTM P/E 52.51

P/B Ratio 11.31

Market Cap (₹) Cr.17,263.77

Dividend Yield (%)0.53

EPS (₹) 29.45

ROE20.18%

Sales Growth (%) 19.2

Profit Growth (%)27.97

Day Range

1,729.951,729.95

L
H

52 Week Range

1,326.902,658.00

L
H

Historical Returns

Returns (6M)

1.6 %

Returns (1Y)

11.07 %

Returns (3Y)

73.9 %

Returns (5Y)

73.9 %

Returns (6M)

1.6 %

Returns (1Y)

11.07 %

Returns (3Y)

73.9 %

Returns (5Y)

73.9 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (28.32%) TTM EPS Growth
  • Company with no debt
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Company with 28.32% positive TTM EPS growth
  • Increasing Annual Revenue for Past 2 Years

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 47.65

MFI 22.66

ATR 148.77

Commodity Channel Index -121.09

ROC125 0.38

ROC21 -21.51

Williams %R -82.75

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current1,707.861,766.381,802.811,671.431,612.911,576.481,517.96
Week Ago1,898.802,104.402,209.801,793.401,587.801,482.401,276.80
Month Ago2,203.702,248.102,274.052,177.752,133.352,107.402,063.00

EMA & SMA
info_icon

1637.85

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 1688.03


9 Day 1897.24


10 Day 1940.83


12 Day 2019.57


14 Day 2028.69

20 Day 2025.81


26 Day 2053.84


50 Day 2106.30


100 Day 2029.95


200 Day 1843.53

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
BNP PARIBAS ARBITRAGEblockSell25 Jan, 2024₹1,421.701,53,421BSE
SOCIETE GENERALEblockBuy25 Jan, 2024₹1,421.701,53,421BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
23 Sept, 2024Chandrashekhar Mukundrao ChawanDisposal₹2,109.401,000BSE
23 Sept, 2024Prakash Lalchand SajnaniDisposal₹2,168.80165,000BSE
04 Sept, 2024Devang BhattDisposal₹1,734.7853333333333333333333333,000BSE
13 Jun, 2024Kanishka KapoorDisposal10,000BSE
05 Jun, 2024Ravi KapoorDisposal10,000BSE
27 Feb, 2024Rajendra ModiDisposal₹1,499.522254,000BSE
27 Feb, 2024Raksha ModiDisposal₹1,492.36552,000BSE
24 Feb, 2024Mr. Chandrashekhar Mukundrao ChawanDisposal₹1,444.9011,000BSE
24 Feb, 2024Raksha ModiDisposal₹1,466.522,000BSE
22 Nov, 2023UTPAL SHETHAcquisition₹1,231.023715415019762845849802253BSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
23 May, 2024Rs.8.7500 per share(875%)Dividend21 Jun, 202422 Jun, 2024

Announcements

DateSourceDetail
21 Feb, 2025BSE IndiaEnclosed herewith the transcripts of Q3/9M-FY25 Earning Call held on the 14th February, 2025
20 Feb, 2025NSE IndiaConcord Biotech Limited has informed the Exchange about General Updates
20 Feb, 2025BSE IndiaEnclosed herewith Intimation regarding successful completion of Inspection by Ministry of Food and Drug Safety (MFDS) at Manufacturing Unit-1 situated at Dholka.
15 Feb, 2025NSE IndiaConcord Biotech Limited has informed the Exchange about Copy of Newspaper Publication
14 Feb, 2025BSE IndiaPursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated January 31, 2025 to the Stock exchanges regarding Earning call in respect of the unaudited (Standalone and Consolidated) Financial Results of the company for third quarter and Nine Months ended December 31, 2024, we wish to inform that the said Earning Call was held today at 04:00 PM (IST).
14 Feb, 2025NSE IndiaConcord Biotech Limited has informed the Exchange about Link of Recording
14 Feb, 2025NSE IndiaConcord Biotech Limited has informed the Exchange about Investor Presentation
14 Feb, 2025BSE IndiaInvestor presentation on Financial results for the Third Quarter and nine months ended on 31st December,2024, is enclosed herewith for record.
13 Feb, 2025NSE IndiaIntegrated filling of financial results for the Third quarter and nine months period ended on 31st December, 2024
13 Feb, 2025NSE IndiaConcord Biotech Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--25 Jan, 202513 Feb, 2025
Quarterly Results--07 Nov, 202411 Nov, 2024
Quarterly Results--01 Aug, 202409 Aug, 2024
Audited Results & Dividend--16 May, 202423 May, 2024
Quarterly Results--31 Jan, 202408 Feb, 2024
Quarterly Results--26 Oct, 202308 Nov, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Concord Biotech

Concord Biotech is a Public Limited Listed company incorporated on 23/11/1984 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1984PLC007440 and registration number is 007440. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1016.94 Cr. and Equity Capital is Rs. 10.46 Cr. for the Year ended 31/03/2024.  Read More

Parent Organisation

Herren Group

Founded

1984

Managing Director

Mr. Sudhir Vaid

NSE Symbol

CONCORDBIO

Concord Biotech Management

NameDesignation
Mr. Sudhir VaidChairman & Managing Director
Mr. Ankur VaidJoint Managing Director & CEO
Mr. Ravi KapoorNon Executive Director
Mr. Rajiv Ambrish AgarwalNon Executive Director
Mrs. Bharti KhannaIndependent Director
Mr. Amitabh ThakoreIndependent Director
Mr. Arvind AgarwalIndependent Director
Mr. Jayaram EaswaranIndependent Director
Dr. Mandayam Chakravarthy SriramanIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
SunPhrmInds₹4,46,576.22₹1,643.75 image
₹1,669.30(-1.53%)
₹1,249.800 - ₹1,960.200
Divis Labora₹1,56,123.40₹5,757.05 image
₹5,978.30(-3.70%)
₹3,350.050 - ₹6,448.750
Cipla₹1,21,675.13₹1,475.75 image
₹1,479.70(-0.27%)
₹1,240.700 - ₹1,702.000
ManKind Phar₹1,18,478.90₹2,327.75 image
₹2,348.45(-0.88%)
₹1,910.100 - ₹3,050.000
DrReddysLab₹1,15,939.04₹1,151.80 image
₹1,170.95(-1.64%)
₹1,104.690 - ₹1,420.200

FAQs on Concord Biotech

What is the share price of Concord Biotech?

The share price of Concord Biotech on 21 Feb, 2025 is ₹ 1,637.85.

What is 52W high and 52W low share price of Concord Biotech?

The highest and lowest 52W share prices of Concord Biotech are ₹ 2658.000 and ₹ 1326.900

What is the market cap of Concord Biotech?

The market capitalization of Concord Biotech as of 21 Feb, 2025 is ₹ 17,263.77 Crores

What is the P/E ratio of Concord Biotech?

The current P/E ratio of Concord Biotech as of 21 Feb, 2025 is 43.99

What is the PB ratio of Concord Biotech?

The PB ratio of Concord Biotech as of 21 Feb, 2025 is 11.31

Top Gainers

948IHFL26I

IBHFL NCD186

₹845.00image

₹705.00 (0.20%)

GREAVESCOT

Greaves

₹281.85image

₹234.90 (0.20%)

ASHSI

Ashirwd Stl

₹45.66image

₹38.05 (0.20%)

CAPRO

Caprola.Chem

₹62.40image

₹52.00 (0.20%)

Top Losers

DHANBANK

Dhanalak.Bnk

₹32.19image

₹35.97 (-0.11%)

08MPD

08MPD

₹8.66image

₹9.62 (-0.10%)

BALTE

BalurghtTran

₹27.13image

₹31.24 (-0.13%)

DARSHANORNA

Darshan Orna

₹4.57image

₹5.07 (-0.10%)

Market Indices

Sensex

₹78,699.07image

₹78,472.48 (0.00%)

Source : Dion Global Solutions Limited